Shad Ahmad

Shad Ahmad

Auto-generated profile, based on publicly available information

Shad Ahmad

Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research NIPER-Raebareli, Lucknow, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2023 in Precision Nanomedicine
Verified
Journal Article
Open access
PDF file
FAFIROZ AHMAD
FIROZ AHMAD
NPNiharika Pandey
Niharika Pandey
KSKratika Singh
Kratika Singh
SAShad Ahmad
Shad Ahmad
MKMohd Khubaib
Mohd Khubaib
RSRolee Sharma
Rolee Sharma
Tuberculosis is the second most fatal infectious disease; each year, it causes millions of deaths worldwide. Although several anti-TB drugs are currently available, the problem with these drugs is that they require a prolonged duration of treatment, with high drug doses. In addition, patient non-adherence to therapy subsequently leads to the development of multidrug-resistant and ex-tensively drug-resistant tuberculosis. Therefore, we need to develop an effective and robust nano-carrier-based drug delivery system to overcome these issues and improve the therapeutic potential of drug dose/duration and patient compliance. This review article focuses on the cur-rently available various nanotechnology-based therapeutic approaches, including lipid nanopar-ticles, polymeric particles, carbon nanotubes, glucan, and alginate-based nano-carrier systems for effective anti-TB drug delivery to host macrophage for mycobacterium killing. Finally, we also present some promising recent nanotechnology-based mycobacterial detection systems us-ing silver nanoparticles, silica nanoparticles, magnetic nanoparticles, quantum dots, and magnet-ic barcode assay that have recently emerged as the latest diagnostic tool. Functionalized nano-materials for emerging Aggregation-induced photodynamic therapy as next-generation theranostics have also been discussed as a novel option for TB diagnosis and therapy.

11 December 2023 in Precision Nanomedicine
Verified
Journal Article
Open access
PDF file
NPNiharika Pandey
Niharika Pandey
FAFIROZ AHMAD
FIROZ AHMAD
KSKratika Singh
Kratika Singh
SAShad Ahmad
Shad Ahmad
RSRolee Sharma
Rolee Sharma
In this era of globalization, there is a need for green synthesis of nanoparticles (NPs), which should lessen the tremendous energy consumption, the utilization of toxic compounds, and time, which can help save the environment from hazardous effects. Green synthesis attempts to utilize products from natural agents like plants and fungi because of their profound availability of bio compounds. The NPs derived from them exhibit anticancer, antibacterial, antimicrobial, antioxidant, anti-diabetic, and immunomodulatory properties because of their unique physical and chemical properties. These extraordinary properties make them promising agents in medicine and agriculture areas. The review has targeted the mush-room-derived NPs and bioactive compounds, including the nutritional content of mushrooms with their multipurpose properties, followed by encapsulation and delivery of the biotherapeutics. These NPs have found significant applications in advancing industrial and biomedical ventures. A complete understanding of the synthesis mechanism will help optimize the synthesis protocols and con-trol the shape and size of NPs.

9 November 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
FAFIROZ AHMAD
FIROZ AHMAD
NFNida Fatima
Nida Fatima
SAShad Ahmad
Shad Ahmad
Tarun Kumar UpadhyayTarun Kumar Upadhyay
Tarun Kumar Upadhyay
PJParul Jain
Parul Jain
RSRolee Sharma
Rolee Sharma
Tuberculosis (TB), attributable to Mycobacterium tuberculosis (M.tb), constitutes a formidable global health challenge, particularly with the proliferation of multidrug-resistant (MDR) strains. The efficacious clearance of M.tb from host cells is imperative for mitigating infection and averting disease progression. Autophagy, an intricate cellular mechanism for degrading and recycling biomolecules, plays a pivotal role in the immune response to M.tb by facilitating the degradation of intracellular pathogens through the formation of autophagosomes and their subsequent fusion with lysosomes. This study elucidates the therapeutic efficacy of DYDGP microparticles in M.tb-infected macrophages. DCFHDA staining elucidated that DYDGP significantly enhances macrophage membrane integrity and amplifies reactive oxygen species (ROS) production compared to YDGP, even in the presence of NOX-2 inhibitors. Furthermore, DYDGP promotes the biogenesis of acidic vesicular organelles and phago-lysosomal maturation, as corroborated by acridine orange and Lysotracker Red staining. Immunofluorescence and dansylcadaverine staining evidenced that DYDGP enhances autophagy induction and LC3 puncta formation in infected macrophages at both 30 min and 24 h. Protein expression analyses demonstrated elevated levels of NOX-2 and LC3, confirming autophagy induction. Antimycobacterial efficacy assessments revealed that DYDGP treatment engendered significant reductions in colony-forming units (CFUs) for H37Rv (64, 40, 19), MDR32420 (44, 35, 18), MDR32422 (44, 39, 21), and MDR32521 (38, 22, 18) at 30 min, 24 h, and 48 h, respectively. These findings accentuate DYDGP's potential to substantially attenuate M.tb burden, including in MDR strains, thereby positioning it as a promising adjunctive therapy for augmenting tuberculosis treatment.

6 June 2024 in Journal of NeuroVirology
Verified
Journal Article
Closed access
PDF file
FAFIROZ AHMAD
FIROZ AHMAD
SAShad Ahmad
Shad Ahmad
AHAdil Husain
Adil Husain
NPNiharika Pandey
Niharika Pandey
MKMohd Khubaib
Mohd Khubaib
RSRolee Sharma
Rolee Sharma

18 January 2026 in Brain Research
Verified
Journal Article
Closed access
SAShad Ahmad
Shad Ahmad
ADIL HUSAINADIL HUSAIN
ADIL HUSAIN
PJParul Jain
Parul Jain
FAFIROZ AHMAD
FIROZ AHMAD

30 April 2026 in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Verified
Journal Article
Open access
PDF file
SAShad Ahmad
Shad Ahmad
ADIL HUSAINADIL HUSAIN
ADIL HUSAIN
NSNitin Kumar Singh
Nitin Kumar Singh
FAFIROZ AHMAD
FIROZ AHMAD
Introduction: Brain disorders, including Parkinson’s disease, epilepsy, traumatic brain injury, and psychiatric illnesses, continue to pose substantial clinical and societal burdens. Traditional treatment approaches are often limited by poor targeting efficiency and the complexity of neural networks. Neuroengineering combines principles of engineering, materials science, and neuroscience to develop innovative tools capable of monitoring and modulating brain activity. Advances in neural interfaces, neurostimulation technologies, and bioengineered therapeutic systems are enabling more precise and minimally invasive treatment strategies, offering new possibilities for restoring neurological function and improving patient outcomes. Short summary: Brain disorders represent one of the greatest challenges in modern medicine, demanding innovative approaches that integrate neuroscience, engineering, and technology. Neuroengineering has emerged as a transformative discipline that bridges these domains, offering new strategies for diagnosis, monitoring, and therapeutic intervention. This review discusses recent advances in neuroengineering technologies, including neural interfaces, neurostimulation systems, nanotechnology-based therapeutics, and tissue engineering approaches supported by artificial intelligence for precision brain disorder management. Conclusion: Neuroengineering represents a rapidly evolving field with the potential to transform brain healthcare through innovative diagnostic and therapeutic technologies. Continued interdisciplinary collaboration and technological refinement are essential to overcome translational challenges and achieve widespread clinical implementation.